Document ID: chunk:federal_register_of_legislation:F2025C00039:reg:73436
Version: federal_register_of_legislation:F2025C00039
Segment Type: reg
Provision Reference: reg 73436
Character Range: 22251–23278

73436              A test of tumour tissue from a patient with a new diagnosis of locally advanced or metastatic non‑small cell lung cancer requested by, or on behalf of, a specialist or consultant physician, if the test is:                                                                                                                                                                                                                                                                                                                                                                                                                                              397.35
                     (a) to determine if the requirements relating to MET proto‑oncogene, receptor tyrosine kinase (MET) exon 14 skipping alterations (METex14sk) status for access to an immunotherapy listed under the Pharmaceutical Benefits Scheme (PBS) are fulfilled: and
                     (b) not associated with a service to which item 73437 or 73438 applies